|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dienstmann R, Vermeulen L, Guinney J,
Kopetz S, Tejpar S and Tabernero J: Consensus molecular subtypes
and the evolution of precision medicine in colorectal cancer. Nat
Rev Cancer. 17:79–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sridharan M, Hubbard JM and Grothey A:
Colorectal cancer: How emerging molecular understanding affects
treatment decisions. Oncology (Williston Park). 28:110–118.
2014.PubMed/NCBI
|
|
4
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hua F, Liu S, Zhu L, Ma N, Jiang S and
Yang J: Highly expressed long non-coding RNA NNT-AS1 promotes cell
proliferation and invasion through wnt/β-catenin signaling pathway
in cervical cancer. Biomed Pharmacother. 92:1128–1134. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ge X, Li GY, Jiang L, Jia L, Zhang Z, Li
X, Wang R, Zhou M, Zhou Y, Zeng Z, et al: Long noncoding RNA CAR10
promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis.
Oncogene. 38:3061–3076. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang D, Cao C, Liu L and Wu D:
Up-Regulation of lncRNA SNHG20 predicts poor prognosis in
hepatocellular carcinoma. J Cancer. 7:608–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B,
Zhang T, Zhou Y, Chen Q, Wei C, et al: Long non-coding RNA SNHG20
promotes non-small cell lung cancer cell proliferation and
migration by epigenetically silencing of P21 expression. Cell Death
Dis. 8:e30922017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu J, Zhao W, Wang Z, Xiang X, Zhang S and
Liu L: Long non-coding RNA SNHG20 promotes the tumorigenesis of
oral squamous cell carcinoma via targeting miR-197/LIN28 axis. J
Cell Mol Med. 23:680–688. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu X, Xiao Y, Zhou Y, Zhou Z and Yan W:
lncRNA SNHG20 promotes prostate cancer migration and invasion via
targeting the miR-6516-5p/SCGB2A1 axis. Am J Transl Res.
11:5162–5169. 2019.PubMed/NCBI
|
|
12
|
Li C, Zhou L, He J, Fang XQ, Zhu SW and
Xiong MM: Increased long noncoding RNA SNHG20 predicts poor
prognosis in colorectal cancer. BMC Cancer. 16:6552016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolf PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan LK, Yao JF and Qiu J: miRNA-495
suppresses proliferation and migration of colorectal cancer cells
by targeting FAM83D. Biomed Pharmacother. 96:974–981. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou C, Tong Y, Wawrowsky K and Melmed S:
PTTG acts as a STAT3 target gene for colorectal cancer cell growth
and motility. Oncogene. 33:851–861. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai Y, Sheng Z, Chen Y and Wang J: LncRNA
HMMR-AS1 promotes proliferation and metastasis of lung
adenocarcinoma by regulating miR-138/sirt6 axis. Aging (Albany NY).
11:3041–3054. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui N, Liu J, Xia H and Xu D: LncRNA
SNHG20 contributes to cell proliferation and invasion by
upregulating ZFX expression sponging miR-495-3p in gastric cancer.
J Cell Biochem. 120:3114–3123. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H
and Jia L: LncRNA SNHG20 knockdown suppresses the osteosarcoma
tumorigenesis through the mitochondrial apoptosis pathway by
miR-139/RUNX2 axis. Biochem Biophys Res Commun. 503:1927–1933.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Xue Y, Liu X, Zheng J, Shen S, Yang
C, Chen J, Li Z, Liu L, Ma J, Ma T and Liu Y: ZRANB2/SNHG20/FOXK1
axis regulates vasculogenic mimicry formation in glioma. J Exp Clin
Cancer Res. 38:682019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li Y, Li
J, Zhu G, Liu Z, Tu Y, et al: miR-495 and miR-551a inhibit the
migration and invasion of human gastric cancer cells by directly
interacting with PRL-3. Cancer Lett. 323:41–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li JZ, Wang ZL, Xu WH, Li Q, Gao L and
Wang ZM: MicroRNA-495 regulates migration and invasion in prostate
cancer cells via targeting akt and mTOR signaling. Cancer Invest.
34:181–188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chu H, Chen X, Wang H, Du Y, Wang Y, Zang
W, Li P, Li J, Chang J, Zhao G and Zhang G: miR-495 regulates
proliferation and migration in NSCLC by targeting MTA3. Tumour
Biol. 35:3487–3494. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu YY, Tian J, Hao Q and Yin LR:
MicroRNA-495 downregulates FOXC1 expression to suppress cell growth
and migration in endometrial cancer. Tumour Biol. 37:239–251. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hwang-Verslues WW, Chang PH, Wei PC, Yang
CY, Huang CK, Kuo WH, Shew JY, Chang KJ, Lee EY and Lee WH: miR-495
is upregulated by E12/E47 in breast cancer stem cells, and promotes
oncogenesis and hypoxia resistance via downregulation of E-cadherin
and REDD1. Oncogene. 30:2463–2474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai Z, Wang J, Wang T, Li Y, Zhao X, Wu G,
Yang Y, Deng W and Zhang Z: The miR-495/Annexin A3/P53 axis
inhibits the invasion and EMT of colorectal cancer cells. Cell
Physiol Biochem. 44:1882–1895. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He Z, Dang J, Song A, Cui X, Ma Z and
Zhang Z: NEAT1 promotes colon cancer progression through sponging
miR-495-3p and activating CDK6 in vitro and in vivo. J Cell
Physiol. 234:19582–19591. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan J, Zhang F and Niu R: Multiple
regulation pathways and pivotal biological functions of STAT3 in
cancer. Sci Rep. 5:176632015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morikawa T, Baba Y, Yamauchi M, Kuchiba A,
Nosho K, Shima K, Tanaka N, Huttenhower C, Frank DA, Fuchs CS and
Ogino S: STAT3 expression, molecular features, inflammation
patterns and prognosis in a database of 724 colorectal cancers.
Clin Cancer Res. 17:1452–1462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang P, Zhao Y, Zhu X, Sedwick D, Zhang X
and Wang Z: Cross-Talk between phospho-STAT3 and PLCγ1 plays a
critical role in colorectal tumorigenesis. Mol Cancer Res.
9:1418–1428. 2011. View Article : Google Scholar : PubMed/NCBI
|
